Nitroderm Tts (Glyceryl Trinitrate)

Glyceryl trinitrate, the active ingredient in Nitroderm Tts, is an organic nitrate presented as a transdermal patch for transdermal use. It reduces myocardial oxygen demand by vasodilating coronary vessels and is indicated for the management of chronic stable angina and for the prophylaxis of angina attacks in adult patients.

GNH USA supplies Nitroderm Tts as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, adhering to EU quality standards and providing reliable global distribution. The company ensures batch‑to‑batch consistency and supports regulatory compliance for its partners.

Nitroderm Tts, an organic nitrate, is used to manage conditions related to coronary artery ischemia.

Chronic stable angina: reduces frequency and severity of angina episodes by improving myocardial blood flow. Prophylaxis of angina attacks: maintains coronary vasodilation to prevent sudden chest pain during exertion. Exercise‑induced angina: enhances exercise tolerance by decreasing cardiac workload.

The most frequently reported adverse reactions with Nitroderm Tts are related to its vasodilatory properties.

Common Side Effects: - Headache: throbbing pain often occurring shortly after patch application. - Flushing: warmth and redness of the skin, especially on the face and neck. - Skin irritation at the patch site: erythema, itching or rash where the patch adheres.

Serious or Rare Side Effects: - Severe hypotension: marked blood pressure fall requiring medical intervention. - Syncope: sudden loss of consciousness related to blood pressure drop. - Methemoglobinemia: rare blood disorder causing reduced oxygen delivery.

When prescribing Nitroderm Tts, clinicians should consider several safety measures.

Cardiovascular status: avoid use in patients with severe hypotension or uncontrolled hypertension. Concomitant PDE5 inhibitors: contraindicated due to risk of profound hypotension. Use with other nitrates: may cause additive vasodilation and severe blood pressure fall. Anemia or increased intracranial pressure: monitor closely as vasodilation may exacerbate symptoms. Pregnancy and lactation: safety not established; prescribe only if benefits outweigh risks. Store at room temperature: keep in original packaging, protect from light and moisture.

Nitroderm Tts can interact with several drug classes; careful assessment is required.

Major Interactions (Avoid): - Phosphodiesterase‑5 inhibitors (e.g., sildenafil, tadalafil, vardenafil): can cause life‑threatening hypotension. - Other organic nitrates (e.g., isosorbide dinitrate, mononitrate): additive vasodilatory effect may lead to severe hypotension. - Riociguat: synergistic vasodilatory action may result in dangerous blood pressure reduction.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may mask tachycardia, requiring blood pressure monitoring. - Calcium‑channel blockers: combined effect can enhance hypotensive response. - Alcohol: can increase vasodilatory effect and dizziness.